This section is designed for Health Care Professionals and covers the latest information available for the treatment and management of SLL and CLL. We aim to keep this area up to date with developments in CLL research.
In 2023, the British Society of Haematology published new guidelines for the treatment of SLL/CLL. The full guidelines are available for review here.
Please scroll down to view each session:
A CLL refresher with gems from ASH23. The complete evening training course.
Chairs: Prof G Follows and Dr R Walewska
This course is aimed at haematologists in training, associate specialists, specialists’ nurses and any other health care provider.
Some of the comments from participants:
“Really superb speakers, great to feel the combination of evidence nuanced with their own personal practice.”
“All really good talks, Helen Marr in particular was excellent.”
“More than brilliant!”
” I thought it was particularly good, engaging and well chaired”
“Excellent presentations correlating research to clinical practice and recommendations.”
The key talks from this very informative seminar can be viewed here:
Chaired by Prof George Follows, Consultant Haematologist, Visiting Professor of Haematology, Anglia Ruskin Medical School, Associate Lecturer, University of Cambridge.
Dr Rosalynd Johnston, Consultant haematologist, University Hospitals Sussex, Royal Sussex County Hospital.
CLL Basic Facts – Dr Rosalynd Johnston and Panel discussion with Dr George Follows; Dr Helen Marr; Dr Piers Patten; and Lelie Duley (patient representative).
Dr Piers Patten, Clinical Senior Lecturer and Honorary Consultant Haematologist, King’s College London.
Clinical trials in the UK plus Q&A – Dr Piers Patten
Dr Helen Marr Consultant Haematologist specialising in chronic lymphocytic leukaemia and lymphoma and autologous bone marrow transplant at NHS Newcastle hospitals.
What’s new in CLL – Dr Helen Marr
Chaired by Dr R Walewska, Consultant Haematologist, University Hospitals, Dorset
Immunosuppression and risk of infection in CLL – plus Q&A – Dr Helen Parry
Professor Adrian Bloor, Consultant Haematologist and MAHSC Honorary Clinical Chair, University of Manchester, Director of Cell Transplantation, The Christie Foundation Trust
Managing autoimmune complications – Prof Adrian Bloor
Dr Nicholas Martinez – Consultant Haematologist (CLL/lymphoma) at Nottingham University Hospital
Richter’s transformation – Dr Nicholas Martinez
Dr Rosalynd Johnston, Consultant haematologist, University Hospitals Sussex, Royal Sussex County Hospital.
CLL – Natural History; presentation; W & W; Complications related to Not CLL Therapy
Dr Ben Kennedy, Consultant Haematologist and Honorary Associate Professor, Department of Haematology, Leicester Royal Infirmary.
CLL – Laboratory Work-Up and Prognostic Biology
Dr Piers Patten, Clinical Senior Lecturer and Honorary Consultant Haematologist, King’s College London.
CLL First Line Therapy – Choices and Considerations
Dr Helen Marr, Consultant Haematologist, Northern Centre for Cancer Care, Freeman Hospital, Newcastle.
CLL Relapsed Therapy – Choices and considerations
Professor Alan Bloor, Consultant Haematologist and MAHSC Honorary Clinical Chair, University of Manchester, Director of Cell Transplantation, The Christie Foundation Trust
Managing Complications of Standard CLL Treatments
Dr Niamh Appleby, Senior Clinical Researcher in Haematology, Molecular Haematology, John Radcliffe Hospital, Oxford.
CLL and Genomica: A New Standard?
UK CLL Forum
Cll Support is the official charity partner of the UK CLL Forum. Follow this link to their website.
UK CLL ForumIntroduction to GP Guide
CLL Support General Practioner Guide
Information for patients
Order our patient information booklet and leaflets here
BSH Good practise paper for Richter's Transformation
A recently published paper from the British Society of Haematologists can be found here
British Society of Haematologists paperDiagnosis and prognosis in CLL/SLL
The webinar was chaired by Prof. Paolo Ghia and featured a presentation on CLL diagnosis and prognostic markers, a case study presentation on a patient with accelerated CLL, a debate on clinically relevant biomarkers, and an audience Q&A session. The other panel members were Prof. Anna Schuh and Dr Davide Rossi. Webinar available here.
Note: this is for HCPs only and registration is required.
